# New Individualized Therapy Trial for Metastatic Colorectal Cancer

> **NCT00867334** · PHASE1,PHASE2 · COMPLETED · sponsor: **Inova Health Care Services** · enrollment: 10 (actual)

## Conditions studied

- Colorectal Neoplasm
- Colorectal Cancer

## Interventions

- **DRUG:** Imatinib mesylate and panitumumab
- **DRUG:** Standard-of-care treatment with panitumumab

## Key facts

- **NCT ID:** NCT00867334
- **Lead sponsor:** Inova Health Care Services
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-06-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00867334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00867334, "New Individualized Therapy Trial for Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00867334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*